All Pharma News
Orexo Q2 2024 Interim Report

Orexo Q2 2024 Interim Report
PR NEWSWIRE
17 Jul 2024
Share Share
Orexo AB´s sustainability work ranked among top 5% by EcoVadis

Orexo AB´s sustainability work ranked among top 5% by EcoVadis
PR NEWSWIRE
10 Jul 2024
Share Share
Orexo: invitation to presentation of the Q2 2024 Interim Report

Orexo: invitation to presentation of the Q2 2024 Interim Report
PR NEWSWIRE
08 Jul 2024
Share Share
Orexo Prospectus, Nasdaq Stockholm Social Bonds Listing

Orexo Prospectus, Nasdaq Stockholm Social Bonds Listing
PR NEWSWIRE
10 May 2024
Share Share
Orexo Q1 2024 Interim Report

Orexo Q1 2024 Interim Report
PR NEWSWIRE
08 May 2024
Share Share
Report from Orexo AB`s annual general meeting, 26 April 2024

Report from Orexo AB`s annual general meeting, 26 April 2024
PR NEWSWIRE
26 Apr 2024
Share Share
Orexo extends patent protection for its nasal epinephrine powder product OX640

Orexo extends patent protection for its nasal epinephrine powder product OX640
INDINPHARMAPOST
22 Apr 2024
Share Share
Orexo Extends US Patent Protection for Nasal Epinephrine OX640

Orexo Extends US Patent Protection for Nasal Epinephrine OX640
PR NEWSWIRE
17 Apr 2024
Share Share
Orexo Announces that The Condition for Early Redemption of Its Existing Bonds

Orexo Announces that The Condition for Early Redemption of Its Existing Bonds
PR NEWSWIRE
02 Apr 2024
Share Share
Orexo publishes the Annual and Sustainability Report for 2023

Orexo publishes the Annual and Sustainability Report for 2023
PR NEWSWIRE
28 Mar 2024
Share Share